1.Effect evaluation of evidence-based nursing on prevention of pulmonary complications in postoperative elderly lung cancer patients
Chinese Journal of Practical Nursing 2012;28(8):1-2
ObjectiveTo discuss the effect of evidence-based nursing on prevention of pulmonary complications in postoperative elderly lung cancer patients.MethodsTwenty elderly lung cancer patients from January to June 2010 were randomly divided into the observation group and the control group with 10 patients in each group.The control group was given regular care methods.The observation group received evidence-based clinical nursing methods.The preventive effect of pulmonary complications was observed in both groups.ResultsOne case was found to have pulmonary complications in the observation group,while four cases in the control group.The total cure rate of the observation group was higher than that of the control group.ConclusionsEvidence-based nursing methods can satisfy the medical demand of patients and their family members to the utmost degree,reduce the incidence of pulmonary complications and contribute to the early recovery of patients.It is worthy of clinical application.
2.Application of seed cells in tissue-engineered articular cartilage
Rui WANG ; Jianning ZHAO ; Sujia WU
Chinese Journal of Tissue Engineering Research 2007;11(23):4654-4657
OBJECTIVE: To expound the research status of the seed cells in tissue-engineered articular cartilage, and explore the resource, in vitro amplification and gene modification, so as to propose the application prospect in future.DATA SOURCES: A computer-based online search of PubMed was undertaken to identify the articles about the seed cells in tissue-engineered articular cartilage published in English between January 1994 and April 2006 with the key words of "cartilage, joint, tissue engineering, stem cell, cell culture, gene modification". Other articles were searched from Tsinghua Tongfang and Vip database according to the journal and article titles.STUDY SELECTION: The data were selected firstly to choose those about the seed cells in tissue-engineered articular cartilage and eliminate those not accorded with the requirements. The full-texts of left articles were searched manually.DATA EXTRACTION: Totally 89 articles were collected, of which 34 were included and 55 were excluded.DATA SYNTHESIS: Cells for the construction of artificial cartilage tissues include autologous or homologous chondrocytes, periost and perichondrium cells, mesenchymal stem cells and embryonic stem cells, all of which could be cultured and amplified by specific culturing system in vitro, they also could be genic modified under certain condition with different strategies and methods to repair articular cartilage defects.CONCLUSION: Seed cells with their particular characteristics play an important role in the repair of articular cartilage defects with tissue engineering technique.
3.The scalfold materials of tissue engineering in articular cartilage repairing
Rui WANG ; Jianning ZHAO ; Sujia WU
Journal of Medical Postgraduates 2003;0(06):-
Tissue engineering technology is a new method to repair articular cartilage defects,and received extensive attention.One of its characters which makes this technology different from a single cell transplantation is the application of scalfold materials.The materials used for scalfold must accord with certain requirements.The previous researches have achieved some break through,but constant improvements still are needed for the alteration from laboratory to clinics.
4.Local biologic reactions induced by wear debris
Junhua WANG ; Jianning ZHAO ; Yurong WANG ; Sujia WU ;
Journal of Medical Postgraduates 2003;0(08):-
Aseptic loosening is the most common cause of implant failure after total hip replacement. Studies have shown that the aseptic loosening is related to the cellular mechanisms involved in the interactions between particulate wear debris from materials used in the prothesis and the surrounding macrophages. A fundamental understanding of how particulate debris incites the release of biologic mediators, such as the proinflammatory/proresorptive cytokines or cellular recruitment, will provide important information regarding the development of interventional therapies to prolong the life of a total hip replacement.
5.Research progresses of atlas fracture
Jun ZOU ; Yurong WANG ; Jianning ZHAO ; Sujia WU
Journal of Medical Postgraduates 2001;14(2):150-153
Atlas fracture is a rare lesion occurred in cervical vertebrae.This review summarize the new approach about the classification,etiological factors,clinical manifestations,diagnosis methods and treatments of the disease.
6.Present state of bone bank
Jun LU ; Sujia WU ; Jianning ZHAO ; Yurong WANG
Journal of Medical Postgraduates 2001;14(2):146-150
Cryopreservation of bone and osteochondryl allografts plays significant role in revision surgery of large bone defects and osteoarticular reconstructive surgery.As a transplantable tissue,bone has the distinct advantage of long-term storage with seemingly little adverse effect.The author reviewed the history and present state of bone bank in the world as well as in our country,and discussed the general principles and methods of donor selection,bone procurement,storage,sterilization,management and the costs associated with this facility.
7.The affecting factors on the bone-healing of allografts
Guangxin ZHOU ; Sujia WU ; Jianning ZHAO ; Yurong WANG
Journal of Medical Postgraduates 2003;0(10):-
s:Bone allografts have been successfully used in repairing bone defect caused by tumor, infection or trauma. The mechanism of bone-healing of allografts has been widely studied. The article reviews the factors affecting the bone-healing of allografts.
8.Clinical significance of expression and phosphorylation of FAK in human osteosarcoma
Ke REN ; Nan YAO ; Jun LU ; Xin SHI ; Sujia WU ; Jie MA ; Chen WANG
Chinese Journal of Clinical Oncology 2017;44(10):474-482
Objective: To examine expression patterns of focal adhesion kinase (FAK) and its activated form, phosphorylated FAK (pFAK),in human osteosarcoma and to investigate the correlation of FAK expression with clinicopathological parameters and prognosis. Functional consequence of manipulating FAK protein levels was also investigated in human osteosarcoma cell lines. Methods: Immunohistochemical staining was used to detect FAK and pFAK levels in pathologically archived materials from 113 patients with primary osteosarcoma. Kaplan-Meier survival and Cox regression analyses were used to evaluate prognoses. The role of FAK in cytological behavior of MG63 and 143B human osteosarcoma cell lines was studied via the FAK protein knockdown with siRNA. Cell proliferation, migration, invasiveness, and apoptosis were assessed using cell counting kit-8, Transwell, and Annexin V/PI staining methods. Results: Both FAK and pFAK were overexpressed in osteosarcoma patients. Tumor cells exhibited cytoplasmicity and occasional membranous immunoreactivity for FAK. A total of 42 cases (37.17%) mainly showed expressed pFAK in cytoplasm of osteosarcoma cells. No overexpression staining of anti-FAK and anti-pFAK antibodies was observed in normal cancellous bone tissues or negative controls. Significant differences were observed in overall survival between FAK-/pFAK- and FAK+/pFAK- groups (P=0.016), FAK+/pFAK- and FAK+/pFAK+ groups (P=0.012), and FAK-/pFAK- and FAK+/pFAK+ groups (P<0.001). All groups showed similar metastasis-free survival. Cox proportional hazard analysis showed that FAK expression profile is an independent indicator of both overall andmetastasis-free survival. siRNA-based knockdown of FAK significantly reducedmigration and invasion of MG63 and 143B cells and affected proliferation and apoptosis in osteosarcoma cells. Conclusion: Osteosarcoma malignancies in vitro and in vivo were correlated with overexpression and phosphorylation of FAK. These findings suggest that FAK plays an important biological role in osteosarcoma carcinogenesis. This study provides a better understanding of diagnostic and prognostic relevance of FAK overexpression and phosphorylation in osteosarcoma patients. Therefore, FAK and pFAK can be used as independent predictors of overall and metastasis-free survival in osteosarcoma patients.
9.Surgical treatment of giant cell tumor of bone around the knee: a multicenter retrospective study
Han WANG ; Yongcheng HU ; Xiuchun YU ; Zhen WANG ; Sujia WU ; Zhaoming YE ; Ningjun WAN ; Ming XU ; Haodong ZHU ; Nong LIN ; Bo HU ; Binbin YUAN
Chinese Journal of Orthopaedics 2012;32(11):1040-1047
Objective To retrospectively analyze treatment status quo of giant cell tumor of bone around the knee in several institutes,and to investigate risk factors affecting selection of surgical manners,tumor recurrence,and functional outcomes.Methods A total of 222 patients with giant cell tumor of bone around the knee confirmed by pathology,who had undergone surgical treatment in 5 institutes from March 2000 to May 2012,were enrolled in this study.There were 120 males and 102 females,with an average age of 35.5 years.The epidemiology,clinical and radiographic features and risk factors affecting selection of surgical manners,tumor recurrence,and functional outcomes were analyzed.Results Intralesional curettage was performed in 128 patients(57.6%),intralesional curettage combined with partial resection in 13 patients (5.8%),and marginal excision in 79 patients (35.5%).A total of 159 patients were followed up.The local recurrence rate was 19.0% for patients treated with intralesional curettage,8.9% for marginal excision and 0% for intralesional curettage combined with partial resection,and the total local recurrence rate was 14.5%(23/159).The mean duration from primary operation to recurrence was 23.9 months.Univariate analysis indicated that surgical manner was the only factor affecting local recurrence.Pathological fracture,Campanacci grades,Enneking system as well as soft tissue mass had a significant influence on the selection of surgical manners.The mean MSTS score after intralesional curettage was obviously higher than that after marginal excision.Conclusion The surgical manner is the only factor affecting local recurrence and limb function.
10.The preliminary report of a randomized controlled multicenter study of first-line chemotherapy regimen combined with angiogenesis inhibitor for osteosarcoma of the extremities
Xin SHI ; Ming XU ; Yuxiu LIU ; Guojing CHEN ; Bing ZHU ; Ping SUN ; Chengjun LI ; Guangxin ZHOU ; Xiaozhou LIU ; Xing ZHOU ; Zhen WANG ; Sujia WU ; Xiuchun YU
Chinese Journal of Orthopaedics 2012;32(11):1027-1031
Objective To evaluate effect and safety of first-line chemotherapy regimen combined with rh-endostatin for osteosarcoma of the extremities.Methods Sixty three patients with osteosarcoma were randomly divided into experiment group and control group.There were 32 patients in experiment group,and 31 patients in control group.Nine patients 9 were rejected because they did not meet the standard.Finally,54 patients were enrolled in this study,including 29 patients in experiment group,and 25 patients in control group.In the experiment group,the patients were treated with rh-endostatin combined with MTX,IFO,DDP,and ADM,while patients in control group were treated with MTX,IFO,DDP,and ADM.Several indexes including median progression-free survival time,clinical benefit rate,progression-free survival rate,limb salvage rate,and survival rate were used to assess clinical effect.The safety of rh-endostatin was evaluated by comparing incidence of adverse events in the two groups.Results The median progression-free survival time of experiment group and control group was 18.9 months and 13.1 months,respectively; there was no significant difference.In the experiment group,the clinical benefit rate,progression-free survival rate,survival rate and limb salvage rate were 89.7%,37.9%,65.5%,and 89.7%,respectively; while in the control group,the clinical benefit rate,progression-free survival rate,survival rate,and limb salvage rate were 88.0%,36.0%,68.0%,and 96.0%,respectively.There was no significant difference in 4 indexes mentioned above between two groups.Conclusion After being combined with first-line chemotherapy regimen,rh-endostatin doesn't show significant advantage in controlling tumour progression and improving survival rate.No more toxicity and new side effects are found after using rh-endostatin.